Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Clinical Trial Comparing Highly Purified FSH Formulation (Fostimon®) and Recombinant FSH (Gonal-F®) in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles.

NCT01969201 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01969201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Clinical Trial Comparing Highly Purified FSH Formulation (Fostimon®) and Recombinant FSH (Gonal-F®) in GnRH-antagonist Controlled Ovarian Hyperstimulation Cycles.
Lead sponsor
IBSA Institut Biochimique SA
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2014
Completion date
August 31, 2017
Enrollment
710 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.